2019³â Äڷγª¹ÙÀÌ·¯½º(»ç½º-CoV-2, ÀϹÝÀûÀ¸·Î COVID-19 ¹ÙÀÌ·¯½º¶ó°í ÇÔ)°¡ È®ÀÎµÈ °Í¸¸ 150¸¸ ¸íÀÌ ³Ñ´Â 184°³±¹À¸·Î È®»êµÆ´Ù. ÀÌ¿Í °°ÀÌ ÁÖ¿äÇÑ ¹ÙÀÌ·¯½º ¹ß»ýÀº Àü·«ÀûÀÎ °èȹ, ¾ïÁ¦ ¹× Ä¡·á¸¦ À§ÇØ ¹ÙÀÌ·¯½º °Ô³ð ¼¿°ú ºÐ·ùÀÇ Á¶±âÇؼ®À» ¿ä±¸ÇÑ´Ù. º» ³í¹®Àº º»ÁúÀûÀÎ COVID-19 ¹ÙÀÌ·¯½º À¯Àüü ¼¸íÀ» ½Äº°ÇÏ°í, À̸¦ ±â°è ÇнÀ ±â¹ÝÀÇ Á¤·Ä-ÀÚÀ¯ Á¢±Ù¹ý°ú ÇÔ²² »ç¿ëÇÏ¿© COVID-19 ¹ÙÀÌ·¯½º À¯ÀüüÀÇ ÃÊ°í¼Ó, È®À强 ¹× °íµµ·Î Á¤È®ÇÑ ºÐ·ù¸¦ Á¦°øÇÑ´Ù.
Á¦ 1Æí : Äڷγª-19ÀÇ Á¤ÀÇ
1. Äڷγª¹ÙÀÌ·¯½º°¨¿°Áõ-19(COVID-19) Á¤º¸ 7
2. Äڷγª¹ÙÀÌ·¯½º ºÐ·ù ¹× Ư¼º 9
3. Äڷγª ¹ÙÀÌ·¯½º ÀüÀÚÇö¹Ì°æ ÇüÅ 11
4. Äڷγª¹ÙÀÌ·¯½º ±¸Á¶ (Covid-19 Organization) 13
5. Äڷγª19: ȯ°æ¿¡ Áö¼ÓÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥±î? 19
6. Ä¡·á¹ý(Therapeutical Method) 22
Á¦ 2Æí : ¿¬±¸³í¹®
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with
COVID-19: A Rapid Systematic Review and Meta-Analysis
Abstract 23
Introduction 23
Materials and methods 26
Results 27
Discussion 33
Conclusion 41
References 41